Protein family
Protein sequence
Protein function
Catalytic activity
EC number
EC number description
2.3.2.27
Transferases;
Acyltransferases;
Aminoacyltransferases;
RING-type E3 ubiquitin transferase
PDB | Resolution (Å) | PDB name |
---|---|---|
1JM7 | Solution structure of the BRCA1/BARD1 RING-domain heterodimer | |
1JNX | 2.5 | Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1 |
1N5O | 2.8 | Structural consequences of a cancer-causing BRCA1-BRCT missense mutation |
1OQA | Solution structure of the BRCT-c domain from human BRCA1 | |
1T15 | 1.85 | Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase |
1T29 | 2.3 | Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide |
1T2U | 2.8 | Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F |
1T2V | 3.3 | Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide |
1Y98 | 2.5 | Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide. |
2ING | 3.6 | X-ray Structure of the BRCA1 BRCT mutant M1775K |
3COJ | 3.21 | Crystal Structure of the BRCT Domains of Human BRCA1 in Complex with a Phosphorylated Peptide from Human Acetyl-CoA Carboxylase 1 |
3K0H | 2.7 | The crystal structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with an amidated C-terminus |
3K0K | 2.7 | Crystal Structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus. |
3K15 | 2.8 | Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with an amidated C-terminus |
3K16 | 3.0 | Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus |
3PXA | 2.55 | Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: G1656D |
3PXB | 2.5 | Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: T1700A |
3PXC | 2.8 | Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1699Q |
3PXD | 2.8 | Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1835P |
3PXE | 2.85 | Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: E1836K |
4IFI | 2.2 | Structure of human BRCA1 BRCT in complex with BAAT peptide |
4IGK | 1.75 | Structure of human BRCA1 BRCT in complex with ATRIP peptide |
4JLU | 3.5 | Crystal structure of BRCA1 BRCT with doubly phosphorylated Abraxas |
4OFB | 3.05 | Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor |
4U4A | 3.51 | Complex Structure of BRCA1 BRCT with singly phospho Abraxas |
4Y18 | 3.5 | Structure of BRCA1 BRCT domains in complex with Abraxas double phosphorylated peptide |
4Y2G | 2.5 | Structure of BRCA1 BRCT domains in complex with Abraxas single phosphorylated peptide |
6G2I | 5.9 | Filament of acetyl-CoA carboxylase and BRCT domains of BRCA1 (ACC-BRCT) at 5.9 A resolution |
7JZV | 3.9 | Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome |
7LYB | 3.28 | Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0006974 | DNA damage response |
Biological Process | GO:0006281 | DNA repair |
Biological Process | GO:0110025 | DNA strand resection involved in replication fork processing |
Biological Process | GO:0071681 | cellular response to indole-3-methanol |
Biological Process | GO:0071479 | cellular response to ionizing radiation |
Biological Process | GO:0071356 | cellular response to tumor necrosis factor |
Biological Process | GO:0007098 | centrosome cycle |
Biological Process | GO:0043009 | chordate embryonic development |
Biological Process | GO:0007059 | chromosome segregation |
Biological Process | GO:0009048 | dosage compensation by inactivation of X chromosome |
Biological Process | GO:0006302 | double-strand break repair |
Biological Process | GO:0000724 | double-strand break repair via homologous recombination |
Biological Process | GO:0006633 | fatty acid biosynthetic process |
Biological Process | GO:0070537 | histone H2A K63-linked deubiquitination |
Biological Process | GO:0035518 | histone H2A monoubiquitination |
Biological Process | GO:0035825 | homologous recombination |
Biological Process | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage |
Biological Process | GO:0051179 | localization |
Biological Process | GO:0007095 | mitotic G2 DNA damage checkpoint signaling |
Biological Process | GO:0044818 | mitotic G2/M transition checkpoint |
Biological Process | GO:0045892 | negative regulation of DNA-templated transcription |
Biological Process | GO:0045786 | negative regulation of cell cycle |
Biological Process | GO:0030308 | negative regulation of cell growth |
Biological Process | GO:0046600 | negative regulation of centriole replication |
Biological Process | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
Biological Process | GO:0045717 | negative regulation of fatty acid biosynthetic process |
Biological Process | GO:0051572 | negative regulation of histone H3-K4 methylation |
Biological Process | GO:0051573 | negative regulation of histone H3-K9 methylation |
Biological Process | GO:0035067 | negative regulation of histone acetylation |
Biological Process | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway |
Biological Process | GO:2000378 | negative regulation of reactive oxygen species metabolic process |
Biological Process | GO:0045739 | positive regulation of DNA repair |
Biological Process | GO:0045893 | positive regulation of DNA-templated transcription |
Biological Process | GO:0045766 | positive regulation of angiogenesis |
Biological Process | GO:0010628 | positive regulation of gene expression |
Biological Process | GO:0051571 | positive regulation of histone H3-K4 methylation |
Biological Process | GO:2000617 | positive regulation of histone H3-K9 acetylation |
Biological Process | GO:0051574 | positive regulation of histone H3-K9 methylation |
Biological Process | GO:2000620 | positive regulation of histone H4-K16 acetylation |
Biological Process | GO:0070512 | positive regulation of histone H4-K20 methylation |
Biological Process | GO:0035066 | positive regulation of histone acetylation |
Biological Process | GO:0031398 | positive regulation of protein ubiquitination |
Biological Process | GO:0045944 | positive regulation of transcription by RNA polymerase II |
Biological Process | GO:0010575 | positive regulation of vascular endothelial growth factor production |
Biological Process | GO:0006301 | postreplication repair |
Biological Process | GO:0085020 | protein K6-linked ubiquitination |
Biological Process | GO:0051865 | protein autoubiquitination |
Biological Process | GO:0000209 | protein polyubiquitination |
Biological Process | GO:0016567 | protein ubiquitination |
Biological Process | GO:2000001 | regulation of DNA damage checkpoint |
Biological Process | GO:0044030 | regulation of DNA methylation |
Biological Process | GO:0006282 | regulation of DNA repair |
Biological Process | GO:0051726 | regulation of cell cycle |
Biological Process | GO:0006349 | regulation of gene expression by genomic imprinting |
Biological Process | GO:0006357 | regulation of transcription by RNA polymerase II |
Biological Process | GO:0043627 | response to estrogen |
Biological Process | GO:0010212 | response to ionizing radiation |
Molecular Function | GO:0003677 | DNA binding |
Molecular Function | GO:0003723 | RNA binding |
Molecular Function | GO:0070063 | RNA polymerase binding |
Molecular Function | GO:0003684 | damaged DNA binding |
Molecular Function | GO:0019899 | enzyme binding |
Molecular Function | GO:0042802 | identical protein binding |
Molecular Function | GO:0002039 | p53 binding |
Molecular Function | GO:0000976 | transcription cis-regulatory region binding |
Molecular Function | GO:0003713 | transcription coactivator activity |
Molecular Function | GO:0015631 | tubulin binding |
Molecular Function | GO:0031625 | ubiquitin protein ligase binding |
Molecular Function | GO:0004842 | ubiquitin-protein transferase activity |
Molecular Function | GO:0008270 | zinc ion binding |
Cellular Component | GO:0070531 | BRCA1-A complex |
Cellular Component | GO:0070532 | BRCA1-B complex |
Cellular Component | GO:0031436 | BRCA1-BARD1 complex |
Cellular Component | GO:0070533 | BRCA1-C complex |
Cellular Component | GO:1990391 | DNA repair complex |
Cellular Component | GO:0001741 | XY body |
Cellular Component | GO:0005694 | chromosome |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0000931 | gamma-tubulin ring complex |
Cellular Component | GO:0043232 | intracellular non-membrane-bounded organelle |
Cellular Component | GO:0000800 | lateral element |
Cellular Component | GO:0001673 | male germ cell nucleus |
Cellular Component | GO:0016604 | nuclear body |
Cellular Component | GO:0000152 | nuclear ubiquitin ligase complex |
Cellular Component | GO:0005654 | nucleoplasm |
Cellular Component | GO:0005634 | nucleus |
Cellular Component | GO:0005886 | plasma membrane |
Cellular Component | GO:0032991 | protein-containing complex |
Cellular Component | GO:1990904 | ribonucleoprotein complex |
Cellular Component | GO:0000151 | ubiquitin ligase complex |
InterPro | InterPro name |
---|---|
IPR001357 | BRCT domain |
IPR001841 | Zinc finger, RING-type |
IPR011364 | Breast cancer type 1 susceptibility protein (BRCA1) |
IPR013083 | Zinc finger, RING/FYVE/PHD-type |
IPR017907 | Zinc finger, RING-type, conserved site |
IPR018957 | Zinc finger, C3HC4 RING-type |
IPR025994 | BRCA1, serine-rich domain |
IPR031099 | BRCA1-associated |
IPR036420 | BRCT domain superfamily |
Pfam | Pfam name |
---|---|
PF00097 | Zinc finger, C3HC4 type (RING finger) |
PF00533 | BRCA1 C Terminus (BRCT) domain |
PF12820 | Serine-rich domain associated with BRCT |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-1221632 | Meiotic synapsis | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | Internal node | R-HSA-73894 | DNA Repair |
R-HSA-5689901 | Metalloprotease DUBs | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | Internal node | R-HSA-73894 | DNA Repair |
R-HSA-5693607 | Processing of DNA double-strand break ends | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-69473 | G2/M DNA damage checkpoint | Internal node | R-HSA-1640170 | Cell Cycle |
R-HSA-8951664 | Neddylation | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-8953750 | Transcriptional Regulation by E2F6 | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-912446 | Meiotic recombination | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-9663199 | Defective DNA double strand break response due to BRCA1 loss of function | Leaf | R-HSA-1643685 | Disease |
R-HSA-9699150 | Defective DNA double strand break response due to BARD1 loss of function | Leaf | R-HSA-1643685 | Disease |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | Leaf | R-HSA-1643685 | Disease |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | Leaf | R-HSA-1643685 | Disease |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | Leaf | R-HSA-1643685 | Disease |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | Leaf | R-HSA-1643685 | Disease |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | Leaf | R-HSA-1643685 | Disease |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | Internal node | R-HSA-8953897 | Cellular responses to stimuli |
Location | ECO term | Pubmed |
---|---|---|
Chromosome | ECO:0000269 | PubMed:23269703 |
Chromosome | ECO:0000269 | PubMed:25472942 |
Chromosome | ECO:0000269 | PubMed:26778126 |
Cytoplasm | ECO:0000269 | PubMed:20160719 |
Cytoplasm | ECO:0000269 | PubMed:8972225 |
Nucleus | ECO:0000269 | PubMed:15133502 |
Nucleus | ECO:0000269 | PubMed:17525340 |
Nucleus | ECO:0000269 | PubMed:20160719 |
Nucleus | ECO:0000269 | PubMed:21144835 |
Nucleus | ECO:0000269 | PubMed:26778126 |
Nucleus | ECO:0000269 | PubMed:9528852 |
HPO ID | HPO name |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0000007 | Autosomal recessive inheritance |
HP:0000010 | Recurrent urinary tract infections |
HP:0000027 | Azoospermia |
HP:0000028 | Cryptorchidism |
HP:0000035 | Abnormal testis morphology |
HP:0000047 | Hypospadias |
HP:0000072 | Hydroureter |
HP:0000079 | Abnormality of the urinary system |
HP:0000083 | Renal insufficiency |
HP:0000130 | Abnormality of the uterus |
HP:0000135 | Hypogonadism |
HP:0000175 | Cleft palate |
HP:0000189 | Narrow palate |
HP:0000215 | Thick upper lip vermilion |
HP:0000218 | High palate |
HP:0000238 | Hydrocephalus |
HP:0000252 | Microcephaly |
HP:0000268 | Dolichocephaly |
HP:0000280 | Coarse facial features |
HP:0000286 | Epicanthus |
HP:0000294 | Low anterior hairline |
HP:0000316 | Hypertelorism |
HP:0000324 | Facial asymmetry |
HP:0000340 | Sloping forehead |
HP:0000347 | Micrognathia |
HP:0000364 | Hearing abnormality |
HP:0000365 | Hearing impairment |
HP:0000426 | Prominent nasal bridge |
HP:0000430 | Underdeveloped nasal alae |
HP:0000453 | Choanal atresia |
HP:0000463 | Anteverted nares |
HP:0000478 | Abnormality of the eye |
HP:0000483 | Astigmatism |
HP:0000486 | Strabismus |
HP:0000492 | Abnormal eyelid morphology |
HP:0000504 | Abnormality of vision |
HP:0000505 | Visual impairment |
HP:0000508 | Ptosis |
HP:0000518 | Cataract |
HP:0000520 | Proptosis |
HP:0000527 | Long eyelashes |
HP:0000568 | Microphthalmia |
HP:0000581 | Blepharophimosis |
HP:0000582 | Upslanted palpebral fissure |
HP:0000639 | Nystagmus |
HP:0000689 | Dental malocclusion |
HP:0000750 | Delayed speech and language development |
HP:0000813 | Bicornuate uterus |
HP:0000819 | Diabetes mellitus |
HP:0000864 | Abnormality of the hypothalamus-pituitary axis |
HP:0000952 | Jaundice |
HP:0000989 | Pruritus |
HP:0001000 | Abnormality of skin pigmentation |
HP:0001053 | Hypopigmented skin patches |
HP:0001172 | Abnormal thumb morphology |
HP:0001199 | Triphalangeal thumb |
HP:0001249 | Intellectual disability |
HP:0001251 | Ataxia |
HP:0001263 | Global developmental delay |
HP:0001347 | Hyperreflexia |
HP:0001392 | Abnormality of the liver |
HP:0001426 | Multifactorial inheritance |
HP:0001428 | Somatic mutation |
HP:0001433 | Hepatosplenomegaly |
HP:0001508 | Failure to thrive |
HP:0001510 | Growth delay |
HP:0001511 | Intrauterine growth retardation |
HP:0001537 | Umbilical hernia |
HP:0001562 | Oligohydramnios |
HP:0001572 | Macrodontia |
HP:0001631 | Atrial septal defect |
HP:0001636 | Tetralogy of Fallot |
HP:0001639 | Hypertrophic cardiomyopathy |
HP:0001643 | Patent ductus arteriosus |
HP:0001646 | Abnormal aortic valve morphology |
HP:0001671 | Abnormal cardiac septum morphology |
HP:0001679 | Abnormal aortic morphology |
HP:0001738 | Exocrine pancreatic insufficiency |
HP:0001760 | Abnormal foot morphology |
HP:0001763 | Pes planus |
HP:0001770 | Toe syndactyly |
HP:0001824 | Weight loss |
HP:0001871 | Abnormality of blood and blood-forming tissues |
HP:0001873 | Thrombocytopenia |
HP:0001882 | Leukopenia |
HP:0001903 | Anemia |
HP:0001945 | Fever |
HP:0002007 | Frontal bossing |
HP:0002017 | Nausea and vomiting |
HP:0002019 | Constipation |
HP:0002023 | Anal atresia |
HP:0002027 | Abdominal pain |
HP:0002039 | Anorexia |
HP:0002119 | Ventriculomegaly |
HP:0002245 | Meckel diverticulum |
HP:0002251 | Aganglionic megacolon |
HP:0002254 | Intermittent diarrhea |
HP:0002414 | Spina bifida |
HP:0002575 | Tracheoesophageal fistula |
HP:0002586 | Peritonitis |
HP:0002650 | Scoliosis |
HP:0002664 | Neoplasm |
HP:0002716 | Lymphadenopathy |
HP:0002817 | Abnormality of the upper limb |
HP:0002823 | Abnormality of femur morphology |
HP:0002827 | Hip dislocation |
HP:0002861 | Melanoma |
HP:0002863 | Myelodysplasia |
HP:0002894 | Neoplasm of the pancreas |
HP:0002896 | Neoplasm of the liver |
HP:0002910 | Elevated hepatic transaminase |
HP:0003002 | Breast carcinoma |
HP:0003003 | Colon cancer |
HP:0003022 | Hypoplasia of the ulna |
HP:0003220 | Abnormality of chromosome stability |
HP:0003270 | Abdominal distention |
HP:0003418 | Back pain |
HP:0003596 | Middle age onset |
HP:0004209 | Clinodactyly of the 5th finger |
HP:0004322 | Short stature |
HP:0004349 | Reduced bone mineral density |
HP:0004389 | Intestinal pseudo-obstruction |
HP:0004396 | Poor appetite |
HP:0005249 | Functional intestinal obstruction |
HP:0005344 | Abnormal carotid artery morphology |
HP:0005522 | Pyridoxine-responsive sideroblastic anemia |
HP:0006101 | Finger syndactyly |
HP:0006265 | Aplasia/Hypoplasia of fingers |
HP:0006501 | Aplasia/Hypoplasia of the radius |
HP:0006725 | Pancreatic adenocarcinoma |
HP:0006824 | Cranial nerve paralysis |
HP:0007400 | Irregular hyperpigmentation |
HP:0007565 | Multiple cafe-au-lait spots |
HP:0007874 | Almond-shaped palpebral fissure |
HP:0008053 | Aplasia/Hypoplasia of the iris |
HP:0008070 | Sparse hair |
HP:0008572 | External ear malformation |
HP:0008678 | Renal hypoplasia/aplasia |
HP:0009623 | Proximal placement of thumb |
HP:0010293 | Aplasia/Hypoplasia of the uvula |
HP:0010469 | Absent testis |
HP:0011027 | Abnormal fallopian tube morphology |
HP:0011463 | Childhood onset |
HP:0011985 | Acholic stools |
HP:0012041 | Decreased fertility in males |
HP:0012125 | Prostate cancer |
HP:0012210 | Abnormal renal morphology |
HP:0012334 | Extrahepatic cholestasis |
HP:0012378 | Fatigue |
HP:0012432 | Chronic fatigue |
HP:0012639 | Abnormal nervous system morphology |
HP:0012745 | Short palpebral fissure |
HP:0025318 | Ovarian carcinoma |
HP:0030084 | Clinodactyly |
HP:0030406 | Primary peritoneal carcinoma |
HP:0040012 | Chromosome breakage |
HP:0040071 | Abnormal morphology of ulna |
HP:0100026 | Arteriovenous malformation |
HP:0100542 | Abnormal localization of kidney |
HP:0100574 | Biliary tract neoplasm |
HP:0100587 | Abnormal preputium morphology |
HP:0100592 | Peritoneal abscess |
HP:0100615 | Ovarian neoplasm |
HP:0100760 | Clubbing of toes |
HP:0100867 | Duodenal stenosis |
Disease name | MONDO ID | ICD10 | ICD10 chapter | OMIM | Orphanet |
---|---|---|---|---|---|
fanconi anemia complementation group a | MONDO:0009215 | D61 | chapter3, Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | OMIM:227650 | |
breast-ovarian cancer, familial, susceptibility to, 1 | MONDO:0011450 | C50 | chapter2, Neoplasms | OMIM:604370 | |
breast-ovarian cancer, familial, susceptibility to, 1 | MONDO:0011450 | C56 | chapter2, Neoplasms | OMIM:604370 | |
pancreatic cancer- susceptibility to- 4 | MONDO:0013685 | C25 | chapter2, Neoplasms | OMIM:614320 | |
familial pancreatic carcinoma | MONDO:0015278 | C25 | chapter2, Neoplasms | OMIM:260350 | Orphanet:1333 |
fanconi anemia, complementation group s | MONDO:0054748 | D61 | chapter3, Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | OMIM:617883 |